1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-08-16 pm EDT
167.96 USD   -4.99%
04:54pMODERNA : Statement of Changes in Beneficial Ownership - Form 4
PU
06:43aModerna, Inc. - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA) AUTHORIZES MODERNA'S OMICRON-CONTAINING BIVALENT BOOSTER IN THE UK
AQ
04:26aJCVI publishes advice on COVID-19 vaccines for autumn booster programme
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Argus Adjusts Moderna's Price Target to $180 From $200, Reiterates Buy Rating

06/09/2022 | 11:42am EDT


© MT Newswires 2022
All news about MODERNA, INC.
04:54pMODERNA : Statement of Changes in Beneficial Ownership - Form 4
PU
06:43aModerna, Inc. - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA) AUTHORIZES M..
AQ
04:26aJCVI publishes advice on COVID-19 vaccines for autumn booster programme
AQ
01:31aUK leads way as it approves first Omicron booster
AQ
08/15Unity Software, Turquoise Hill fall; Gilead, Moderna rise
AQ
08/15SECTOR UPDATE : Health Care Stocks Carried Higher with Monday Markets
MT
08/15SECTOR UPDATE : Health Care Stocks Staying on Positive Ground
MT
08/15Moderna Says Bivalent COVID-19 Booster Vaccine Receives Conditional Authorization in UK..
MT
08/15British regulator 1st to OK Moderna's updated COVID booster
AQ
08/15Britain first country to approve updated Moderna COVID-19 vaccine
AQ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 21 892 M - -
Net income 2022 11 063 M - -
Net cash 2022 16 818 M - -
P/E ratio 2022 6,36x
Yield 2022 -
Capitalization 65 706 M 65 706 M -
EV / Sales 2022 2,23x
EV / Sales 2023 4,46x
Nbr of Employees 2 700
Free-Float 90,4%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 167,96 $
Average target price 214,00 $
Spread / Average Target 27,4%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-33.87%69 156
IQVIA HOLDINGS INC.-12.01%46 302
LONZA GROUP AG-25.21%44 721
SEAGEN INC.9.01%31 083
ALNYLAM PHARMACEUTICALS, INC.36.22%27 727
CELLTRION, INC.6.57%21 868